Key Takeaway: CorMedix Therapeutics has announced its participation in the RBC Capital Markets Global Healthcare Conference and the Jefferies Global Healthcare Conference, both hosted in New York. The events will allow the company's management to engage in discussions through fireside chats and investor meetings. These conferences are set for May 19-20 and June 2-4, 2026, respectively, providing a platform for CorMedix to showcase its commitment to developing therapeutic products for severe medical conditions.
Price reaction · baseline $7.93 (2026-05-14 close) · hit after-hours · clean, no other CRMD news in the window
day 0 close · peak
-4.8%
Conference Participation Details
Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
Archived versions will be available following the live events for a limited time.
Market Sentiment Analysis
POSITIVE FACTORS
Participation in major healthcare conferences enhances visibility.
Opportunities for networking with investors and stakeholders.
Focus on life-threatening conditions showcases strong therapeutic intent.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+42%
120-day peak, hindsight
Typical move
27.2%
average across 3 past catalysts
Lead asset
Solithromycin
Phase 3 · Community-acquired Bacterial Pneumonia
Full Press Release Details
PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:
RBC Capital Markets Global Healthcare Conference
Date:
Wednesday, May 20, 2026
Time:
11:00am EDT
Webcast:
Click here
Jefferies Global Healthcare Conference
Date:
Wednesday, June 3, 2026
Time:
4:20pm EDT
Webcast:
Click here
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com.
Frequently Asked Questions
When is CorMedix participating in the RBC Conference?
CorMedix will join the RBC Capital Markets Conference on May 20, 2026.
What time is the Jefferies Conference fireside chat?
The Jefferies Conference fireside chat is at 4:20 PM EDT on June 3, 2026.
Where will the investor meetings take place?
Investor meetings will occur at the RBC and Jefferies conferences in New York.
What does CorMedix Therapeutics specialize in?
CorMedix focuses on therapeutic products for critical conditions and diseases.
How does CorMedix operate in the US market?
CorMedix markets products in US institutional care settings, including hospitals.